Keywords: alta, partners, invests, 25m, anesiva, life, sciences
Alta Partners invests $25M in Anesiva
Article | 24 December 2007
Alta Partners, a US life sciences venture capital firm, has announced a $25.0 million investment in Anesiva, a late-stage biopharmaceutical company ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
